Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development

Cancer Research

Volumn 62, Issue 9, 2002, Pages 2516-2521

  Bol, David K ^a   Rowley, R Bruce ^a   Ho, Ching Ping ^a   Pilz, Brigette ^a   Dell, Janet ^a   Swerdel, Mavis ^a   Kiguchi, Kaoru ^b   Muga, Stephanie ^b   Klein, Russell ^b   Fischer, Susan M ^b  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; GENE OVEREXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; PROTEIN EXPRESSION; SKIN CANCER; SKIN CARCINOGENESIS; TRANSGENIC MOUSE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ALOPECIA; ANIMALS; CARCINOGENS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; FEMALE; HAIR FOLLICLE; HUMANS; ISOENZYMES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED ICR; MICE, TRANSGENIC; PHENOTYPE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; SKIN; SKIN NEOPLASMS; SULFONAMIDES; TETRADECANOYLPHORBOL ACETATE;

EID: 0036569925     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. v-Src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor
2. Cyclooxygenases. Structural, cellular and molecular biology
3. Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis
4. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
5. Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane-induced colonic tumors in rats
6. Cyclooxygenase-2 gene expression in human breast cancer
7. Increased expression of cyclooxygenase-2 occurs frequently in human lung cancers, specifically in adenocarcinomas
8. Expression of cyclooxygenase-2 in prostate carcinoma
9. Increased cyclooxygenase-2 levels in carcinogen-induced rat and colonic tumors
10. Elevated cyclooxygenase-2 levels in min mouse adenomas
11. Chemopreventive activity of celecoxib, a specific cyclooxygenase inhibitor and indomethacin against ultraviolet light-induced skin carcinogenesis
12. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing cyclooxygenase-2
13. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
14. 2 in human colon cancer cells
15. Cyclooxygenase-2 regulates induced by colon cancer cells
16. 2 inhibits TNF-α release via a mechanism involving IL-10
17. Inhibition of lung tumorigenesis by sulindac: Comparison of two experimental protocols
18. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis
19. 716 knockout mice by inhibition of cyclooxygenase-2 (COX-2)
20. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor against colon carcinogenesis
21. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells
22. Malignant transformation and antineoplastic actions of nonsteroidal anti-inflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts
23. The effect of non-steroidal antiinflammatory drugs on proliferation an on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway
24. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels
25. Sulfone metabolite of sulindac inhibits mammary carcinogenesis
26. Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis
27. Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype
28. Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure
29. Identification of an immediate early gene, PGHS-B, whose protein product has prostaglandin-synthase/cyclooxygenase activity
30. Effects of dietary fat on phorbol ester elicited tumor promotion and other events in mouse skin
31. FVB/N mice: An inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin
32. Enhancement of susceptibility to diverse skin tumor promoters by activation of the insulin-like growth factor-1 in the epidermis of transgenic mice
33. Molecular and cellular biology of keratins
34. A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis
35. Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin
36. Prostaglandin hydroperoxidase-dependent activation of heterocyclic aromatic amines
37. Carcinogen substrate specificity of human COX-1 and COX-2
38. Eicosanoids and multistage carcinogenesis in NMR1 mouse skin: Role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion)
39. Indomethacin enhancement of TPA tumor promotion in mice
40. Prostaglandin modulation of phorbol ester skin tumor promotion
41. The effect of exogenous prostaglandin administration on tumor size and yield in Min/+ mice
42. Overexpression of cyclooxygenase-2 induces cell cycle arrest: Evidence for a prostaglandin-independent mechanism
43. Prostaglandins, cyclic nucleotides and the effect of phorbol ester tumor promoters on mouse skin in vivo
44. Localization of prostaglandin synthase isozymes in murine epidermal tumors: Suppression of skin tumor promotion by inhibition of prostaglandin H synthase-2
45. Effects of cyclooxygenase deficiency on inflammation and papilloma formation in mouse skin
46. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice
47. Peroxisome proliferator-activated receptors: Insight into multiple cellular functions
48. Activators of peroxisome proliferator-activated receptor alpha partially inhibits mouse skin tumor promotion
49. PPARγ induces cell cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A
50. Diversity of mouse lipoxygenases: Identification of a subfamily of epidermal isozymes exhibiting a differentiation-dependent mRNA expression pattern
51. Lipoxygenase metabolites of arachidonic and linoleic acids modulate the adhesion of tumor cells to endothelium via regulation of protein kinase C
52. 12(S)-HETE is a mitogenic factor for microvascular endothelial cells: Its potential role in angiogenesis